000 | 01973 a2200601 4500 | ||
---|---|---|---|
005 | 20250517190430.0 | ||
264 | 0 | _c20190708 | |
008 | 201907s 0 0 eng d | ||
022 | _a2379-3708 | ||
024 | 7 |
_a10.1172/jci.insight.95978 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChang, Shih-Yu | |
245 | 0 | 0 |
_aHuman liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity. _h[electronic resource] |
260 |
_bJCI insight _c11 2017 |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAristolochic Acids _xtoxicity |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 | _aBiotransformation |
650 | 0 | 4 |
_aCarcinogens _xtoxicity |
650 | 0 | 4 |
_aDicumarol _xmetabolism |
650 | 0 | 4 | _aEpithelial Cells |
650 | 0 | 4 |
_aHepatocytes _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney _xdrug effects |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xmetabolism |
650 | 0 | 4 |
_aNAD(P)H Dehydrogenase (Quinone) _xmetabolism |
650 | 0 | 4 |
_aNephrons _xdrug effects |
650 | 0 | 4 |
_aPathology, Molecular _xinstrumentation |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aRenal Insufficiency, Chronic |
650 | 0 | 4 | _aXenobiotics |
700 | 1 | _aWeber, Elijah J | |
700 | 1 | _aSidorenko, Viktoriya S | |
700 | 1 | _aChapron, Alenka | |
700 | 1 | _aYeung, Catherine K | |
700 | 1 | _aGao, Chunying | |
700 | 1 | _aMao, Qingcheng | |
700 | 1 | _aShen, Danny | |
700 | 1 | _aWang, Joanne | |
700 | 1 | _aRosenquist, Thomas A | |
700 | 1 | _aDickman, Kathleen G | |
700 | 1 | _aNeumann, Thomas | |
700 | 1 | _aGrollman, Arthur P | |
700 | 1 | _aKelly, Edward J | |
700 | 1 | _aHimmelfarb, Jonathan | |
700 | 1 | _aEaton, David L | |
773 | 0 |
_tJCI insight _gvol. 2 _gno. 22 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1172/jci.insight.95978 _zAvailable from publisher's website |
999 |
_c27851659 _d27851659 |